These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25125465)

  • 41. Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion.
    Sun Y; Yao J; Kim TW; Tall AR
    J Biol Chem; 2003 Jul; 278(30):27688-94. PubMed ID: 12754201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lamotrigine Reduces β-Site AβPP-Cleaving Enzyme 1 Protein Levels Through Induction of Autophagy.
    Wu H; Lu MH; Wang W; Zhang MY; Zhu QQ; Xia YY; Xu RX; Yang Y; Chen LH; Ma QH
    J Alzheimers Dis; 2015; 46(4):863-76. PubMed ID: 25854934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.
    Sieczkowski E; Milenkovic I; Venkataramani V; Giera R; Ströbel T; Höftberger R; Liberski PP; Auff E; Wirths O; Bayer TA; Kovacs GG
    J Alzheimers Dis; 2015; 44(1):103-14. PubMed ID: 25182745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific Triazine Herbicides Induce Amyloid-β42 Production.
    Portelius E; Durieu E; Bodin M; Cam M; Pannee J; Leuxe C; Mabondzo A; Oumata N; Galons H; Lee JY; Chang YT; Stϋber K; Koch P; Fontaine G; Potier MC; Manousopoulou A; Garbis SD; Covaci A; Van Dam D; De Deyn P; Karg F; Flajolet M; Omori C; Hata S; Suzuki T; Blennow K; Zetterberg H; Meijer L
    J Alzheimers Dis; 2016 Oct; 54(4):1593-1605. PubMed ID: 27589520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
    Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
    Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease.
    Hartlage-Rübsamen M; Waniek A; Meissner J; Morawski M; Schilling S; Jäger C; Kleinschmidt M; Cynis H; Kehlen A; Arendt T; Demuth HU; Rossner S
    Acta Neuropathol; 2015 Apr; 129(4):565-83. PubMed ID: 25666182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
    Cras P; Kawai M; Siedlak S; Mulvihill P; Gambetti P; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
    Am J Pathol; 1990 Aug; 137(2):241-6. PubMed ID: 2117395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons.
    Kim WS; Chan SL; Hill AF; Guillemin GJ; Garner B
    J Alzheimers Dis; 2009; 16(1):121-31. PubMed ID: 19158428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease.
    Kågedal K; Kim WS; Appelqvist H; Chan S; Cheng D; Agholme L; Barnham K; McCann H; Halliday G; Garner B
    Biochim Biophys Acta; 2010 Aug; 1801(8):831-8. PubMed ID: 20497909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.
    Soejima N; Ohyagi Y; Nakamura N; Himeno E; Iinuma KM; Sakae N; Yamasaki R; Tabira T; Murakami K; Irie K; Kinoshita N; LaFerla FM; Kiyohara Y; Iwaki T; Kira J
    Curr Alzheimer Res; 2013 Jan; 10(1):11-20. PubMed ID: 22950910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
    Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
    FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of ABC transporters in the pathogenesis of Alzheimer's disease.
    Abuznait AH; Kaddoumi A
    ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease.
    Li M; Yuan Y; Hu B; Wu L
    J Mol Neurosci; 2017 Apr; 61(4):489-497. PubMed ID: 28124230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholesterol, lipids, amyloid Beta, and Alzheimer's.
    Vestergaard M; Hamada T; Morita M; Takagi M
    Curr Alzheimer Res; 2010 May; 7(3):262-70. PubMed ID: 19715550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.
    Phiel CJ; Wilson CA; Lee VM; Klein PS
    Nature; 2003 May; 423(6938):435-9. PubMed ID: 12761548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.